ALISHA SAMNANI: Open Payments
NPI 1891484747 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 42 payments from 16 companies in 2025. Trend: 2023 $188 · 2024 $685 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $233 |
| AstraZeneca Pharmaceuticals LP | 4 | $169 |
| PFIZER INC. | 3 | $73 |
| Averitas Pharma Inc. | 2 | $55 |
| SANOFI-AVENTIS U.S. LLC | 1 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Boston Scientific Corporation | 1 | $43 |
| Astellas Pharma US Inc | 3 | $42 |
| SANOFI PASTEUR INC. | 1 | $37 |
| Dexcom, Inc. | 2 | $35 |
Products named: FARXIGA, Ozempic, Wegovy, PREVNAR 20, QUTENZA, TZIELD, GEMTESA, APOLLO ESG System.
Industry payments across TX — which companies pay providers there.
